MedTrace Logo

Effectiveness of Chinese Handwriting Intervention Program for Children With ASD

NCT05841511 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2024-03-12

No results posted yet for this study

Summary

This research aims to investigate the effectiveness and acceptability of the newly developed Chinese handwriting performance intervention program

Conditions

Interventions

BEHAVIORAL

Chinese handwriting intervention program for children with ASD, named "Go Go Handwriting - ASD version"

The intervention program was developed and finalized by a group of occupational therapist specialists in the pediatric field. Thirty-six 20-minute activities with twelve activities for each handwriting fundamental skill were designed in this program. All intervention activities were designed based on the characteristic of Chinese characters and included different types of characters. The activities designed will also be graded according to the following principle: (1) the similarities between the character given, (2) the complexity of the figure or character in the activities, and (3) the frequency and level of therapist assistance. Furthermore, a playful and interesting intervention context will also be integratedinto the program with the design of the adventure journey of an astronaut to further facilitate the motivation and participation of the participants in our program.

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
6 Years
Max Age
9 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-07
Primary Completion
2023-05-04
Completion
2023-05-04

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05841511 on ClinicalTrials.gov